Frank O'Donnell

Frank O'Donnell

Chief Executive Officer presso INHIBITOR THERAPEUTICS, INC.

Patrimonio netto: 3 800 $ in data 30/04/2024

74 anni
Health Technology
Consumer Services
Finance

Posizioni attive di Frank O'Donnell

SocietàPosizioneInizioFine
INHIBITOR THERAPEUTICS, INC. Chief Executive Officer 13/12/2022 -
Chairman 13/12/2022 -
Chief Executive Officer 01/01/1999 -
Founder 26/03/2011 -
Private Equity Investor 01/01/1999 -
Chairman 01/01/1999 -
Chief Investment Officer 01/01/1999 -
Health Careers Foundation Director/Board Member - -
Chairman 08/06/2010 -
St. Louis University Director/Board Member 07/04/2011 -
Defender Pharmaceuticals, Inc. Chairman - -

Storia della carriera di Frank O'Donnell

Precedenti posizioni note di Frank O'Donnell

SocietàPosizioneInizioFine
BIODELIVERY SCIENCES INTERNATIONAL, INC. Director/Board Member 21/05/2018 12/05/2020
Chief Executive Officer 09/10/2000 22/08/2005
Chairman 09/10/2000 21/05/2018
Founder 09/10/2000 12/05/2020
INHIBITOR THERAPEUTICS, INC. Chairman 02/08/2013 22/11/2016
Chairman 01/06/2003 01/03/2013
President 01/06/2003 26/07/2012
░░░░░ ░░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ - -
░░░░░ ░░░░░░░░░ ░░░░░░░ - -
░░░░░░░ - -
░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░ - -
░░░░░ ░░░░░ ░░░░░░░░░░ ░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ - -
░░░░░░░ ░░░░░░░░░ ░░░░░░░░ ░░░ ░░░░░░░ ░░░░░░░░░░ -
░░░░░░░░░ ░░░░░░░░░░░░░░░░░ - ░░░░░░░░░░
░░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░ - -
░░░░░░░ ░░░░░░░░░░ -
░░░░░░░░ ░░░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░ ░░░░░░░░░░ -
░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░

Formazione di Frank O'Donnell

The Johns Hopkins University School of Medicine Undergraduate Degree

Statistiche

Distribuzione geografica

Stati Uniti 16

Posizioni

Chairman 9
Founder 6
Director/Board Member 4

Settori

Health Technology 6
Consumer Services 4
Finance 3

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società collegate

Società quotate in Borsa1
INHIBITOR THERAPEUTICS, INC.

Health Technology

Aziende private11

Finance

Health Technology

Health Technology

Health Technology

Distribution Services

Health Careers Foundation

Health Technology

Commercial Services

Finance

Repurposed Therapeutics, Inc.

Defender Pharmaceuticals, Inc.

Vedi le connessioni aziendali